2021-11-16-世界卫生组织-Cervical_cancer_Spain_2021_country_profile_1页_64kb

SPAIN CERVICAL CANCER PROFILE SUMMARY

Morbidity and Mortality:

• Incidence: Cervical cancer has a relatively low crude and age-standardized incidence rate in Spain in 2020 (7.4/100,000 and 5.9/100,000 respectively).
• Mortality: In 2019, about 211,000 female deaths were attributed to cervical cancer, with a mortality incidence ratio of 0.42 in 2020.
• Registry Data: Population-based cancer registry data is available (as per 2021).
• POPULATION Data: Population data and female deaths are confirmed, cited for 2019.

Primary Prevention (HPV Vaccination):

• Programme Coverage: Spain has a National HPV Vaccination Programme introduced in 2007.
• Vaccination Details: The scale was defined for the cohort born by 1992 (age 15 pre-puberty). By 2020, overall coverage among 9-14-year-old girls was reported at 80% by age 15. Over 80% (79-84%) of girls were vaccinated by age 15 (final dose received). HPV is included nationally, and >90% of girls born in 1995/2003 received the recommended doses by age 15 (specific target reached in 2019).
• Coverage Type: Coverage aims at ages under 15 for pre-pubertal vaccination.
• Risk Factors Data: Data on tobacco use, condom use, and HIV incidence is available (though tobacco data notes absence of total data).

Secondary Prevention (Screening):

• Programme: A National Screening Programme for cervical cancer exists (updated 2021) using cytology (and HPV test from age 35).
• Target Age: Aged 25 to 65 years for screening.
• Acceptability & Guidelines: About 83-88% of women have been screened in the last 5 years or use screening regularly. Treatment guidelines exist. There is a well-defined referral system from primary to secondary/tertiary care.

Treatment and Supportive Care:

• Resources: Cancer centers and specialized departments exist at tertiary level. Data on medical, radiation, and pathologic resources are available, showing presence of key personnel/units (e.g., surgeons, radiation oncologists, radiologists, pathologists).
• Cancer Services: Number of cancer patients treated generally increases year by year (2017-2020). Data on specific resource configurations vary in reporting year, showing sufficient capacity existing.
• Opioid Consumption: This data (2017) pertains to morphine availability, focus is on cancer services potentially linked indirectly to supportive/palliative care capacity.

WHO Elimination Target: Goals for the strategy exist but specific attainment data isn't detailed here based on the provided profile overview.
Disclaimer: "ND" denotes data not available for certain indicators.